Funding for this research was provided by:
Novartis Institutes for BioMedical Research (The study was conducted through a public-private partnership funded by Novartis)
Received: 2 November 2017
Accepted: 24 June 2018
First Online: 3 July 2018
Ethics approval and consent to participate
: The study was registered on clinicaltrials.gov (#NCT02661763) and approved by the Biomedical Research Ethics Committee at the University of Zambia (REF. No. 002–10-13 on 6th December 2013), the Ministry of Health, the Ministry of Education, and the Ministry of Community Development, Mother and Child Health. Written informed consent for participation in the study was required from parents or legal guardians. Children were verbally informed about the study at the time of screening and were required to provide written assent with their name or thumbprint in order to participate.
: The manuscript does not contain any individual person’s data. The student photographed in Fig. InternalRef removed provided written consent for use of the photo.
: SS, JS, MG, JVD, and LC are employees of Novartis.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.